搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
1 天
Can Taking Antidepressants Cause Weight Loss?
If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...
10 天
on MSN
Q&A: Why are antidepressants underprescribed?
The University of Virginia's Dr. Anita Clayton has been a primary investigator for nearly every antidepressant approved in ...
来自MSN
2 天
Weighing in on weight gain from antidepressants
If you’re struggling with depression, the most important question about taking an antidepressant is whether it will work. But ...
Managed Healthcare Executive
2 天
FDA Approves Spravato Nasal Spray as a Standalone Treatment for Major Depressive Disorder
One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...
2 天
J&J's ketamine-derived nasal spray approved by FDA to treat depression
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...
1 天
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
3 天
10 Most Common Causes Behind Unexpected Weight Gain
Conditions like heart failure, kidney problems, or hormonal fluctuations can cause the body to retain excess fluid, leading ...
Healthline
14 天
How to Wean Off Antidepressants: Safety and Withdrawal Prevention
Most people experience mild symptoms if they ... The table below lists some common antidepressants and shows the approximate time it may take for half of the drug to leave your body (also ...
2 天
on MSN
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
3 天
J&J wins label expansion for depression therapy Spravato
Johnson & Johnson (JNJ) stock in focus as FDA expands the label for its depression therapy Spravato (esketamine) allowing its ...
2 天
on MSN
FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
12 天
on MSN
Woman ‘suicidal’ after taking same antidepressants as Thomas Kingston issues warning ...
A woman who said she has become severely suicidal during a year of being prescribed the same antidepressants as royal family ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈